Loading...
 

January - March 2018: 
Volume 31, Issue 1

Click on the image to download the Issue in PDF format.

ARCHIVE

Pneumon 2018, 31(1):11-13
Non Tuberculous Mycobacterial Infection From Oscar Wilde to Gene Sequencing
Authors Information
1First Academic Department of Pneumonology, Interstitial Lung Diseases Unit, Hospital for Diseases  of the Chest, “Sotiria”, Medical School,  National and Kapodistrian University  of Athens, Athens, Greece
References

References

1.  Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.

2.  Ballard DH, Previgliano CH. Lady Windermere Syndrome. Am J Med Sci 2016; 351:e7.

3.  Donatelli C, Mehta AC. Lady Windermere syndrome: Mycobacterium of sophistication. Cleve Clin J Med 2015; 82:641-3.

4.  Ryu YJ, Koh WJ, Daley CL. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians’ Perspectives. Tuberc Respir Dis (Seoul) 2016; 79:74-84.

5.  Philley JV, Wallace RJ, Jr., Benwill JL, et al. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Chest 2015; 148:499-506.

6.  Peloquin C. The Role of Therapeutic Drug Monitoring in Mycobacterial Infections. Microbiol Spectr 2017; 5(1): doi: 10.1128/microbiolspec. TNMI7-0029-2016.

7.  Egelund EF, Fennelly KP, Peloquin CA. Medications and monitoring in nontuberculous mycobacteria infections. Clin Chest Med 2015; 36:55-66.

8.  Cowman S, Burns K, Benson S, Wilson R, Loebinger MR. The antimicrobial susceptibility of non-tuberculous mycobacteria. J Infect 2016; 72:324-31.

9.  Wallace RJ, Jr., Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46:3164-7.

10.  Mitchell JD. Surgical approach to pulmonary nontuberculous mycobacterial infections. Clin Chest Med 2015; 36:117-22.